BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33115978)

  • 1. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
    Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
    Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
    Zhang H; Lu J; Jiang C; Lu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis.
    Cao W; Sun Y; Liu L; Yu J; Ji J; Wang Y; Yang J
    Bioengineered; 2022 Mar; 13(3):6567-6578. PubMed ID: 35227173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
    Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
    Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
    World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
    Yi L; Ouyang L; Wang S; Li SS; Yang XM
    J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
    Deng G; Wang F; Song Y
    Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated long non-coding RNA SNHG7 restricts proliferation and boosts apoptosis of nasopharyngeal carcinoma cells by elevating microRNA-140-5p to suppress GLI3 expression.
    Dai Y; Zhang X; Xing H; Zhang Y; Cao H; Sang J; Gao L; Wang L
    Cell Cycle; 2020 Feb; 19(4):448-463. PubMed ID: 31944163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].
    Zhang J; Bai HJ
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1062-1068. PubMed ID: 34695896
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non‑coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR‑454/USP47 axis.
    Yuan F; Lou Z; Zhou Z; Yan X
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 19. Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis.
    Ai J; Tan G; Li W; Liu H; Li T; Zhang G; Zhou Z; Gan Y
    Cell Biol Toxicol; 2023 Apr; 39(2):537-556. PubMed ID: 35844005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.
    Li H; Huang J; Yu S; Li H; Zhou Y; Wu Q
    Oncol Lett; 2021 Jun; 21(6):493. PubMed ID: 33968209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.